EUVIMEDEUVIMED entdecken
ZwillingsstudieOpen Access · CC BY 4.0

Metformin and incident osteoarthritis: Causal insights from a co-twin control study

Karin Magnusson, Aleksandra Turkiewicz, Andrea Dell'Isola, Ali Kiadaliri, Martin Englund

Osteoarthritis and Cartilage · 2026

DOI: 10.1016/j.joca.2025.12.014 ↗

Kurz gefasst

Zwillingsstudie in der Zeitschrift Osteoarthritis and Cartilage, 2026. Verfasst von Karin Magnusson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Remissgatan 4, Lund 222 4…. Hauptthemen laut MEDLINE: Metformin, Osteoarthritis, Hypoglycemic Agents, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Greta och Johan Kocks stiftelser, Karolinska Institutet, Reumatikerförbundet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: In a co-twin control design, we aimed to examine whether individuals who initiate metformin treatment have an altered risk of incident diagnosis of osteoarthritis (OA), for up to 11 years after starting the treatment, compared with their non-treated co-twin. METHODS: In all twin pairs different for metformin treatment (N=1 261 pairs) and all eligible twins/singletons (N=52 341) aged 35-75 years living in Sweden on December 31st 2005, without prior diagnosis of OA and no prior treatment with metformin, we studied the outcome OA in any joint as diagnosed in specialist care. We used a stratified Cox model in discordant pairs to estimate hazard ratio (HR) and a within-between Weibull shared frailty model to estimate incidence proportions and differences. Models were adjusted for age, sex, education level, body mass index (BMI) and smoking. RESULTS: Among treated twins, 68 (5.4%) developed OA over the 11-year follow-up, compared to 79 (6.3%) among the non-treated twins (crude HR [95% confidence interval -CI] = 0.86 [0.62-1.19]). Treated twins had higher BMI. Adjusted HR comparing treated with non-treated was 0.60 (95% CI =0.44-0.82). After 10 years, 6.7% (95% CI=4.8-8.6) of treated twins, compared to 9.7% (95% CI=9.3-10.1) of non-treated twins had incident OA, with difference of -3.1% (95% CI=-5.1- (-1.1)). CONCLUSION: Starting metformin treatment may be associated with a decreased risk of incident diagnosis of OA in specialist care over an 11-year follow-up period. The 10-year cumulative incidence was ∼3 percentage points lower among metformin initiators than non-initiators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminOsteoarthritisHypoglycemic AgentsDiabetes Mellitus, Type 2HumansFemaleIncidenceMiddle AgedAgedMaleSwedenAdultRisk FactorsProportional Hazards Models

Stichwörter der Autor:innen

DiabetesGeneticsMetforminOsteoarthritis

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Remissgatan 4, Lund 222 42, Sweden; Norwegian Institute of Public Health, Cluster for Health Se…
  • Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Remissgatan 4, Lund 222 42, Sweden. Electronic address: Aleksandra.turkiewicz@med.lu.se.
  • Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Remissgatan 4, Lund 222 42, Sweden. Electronic address: andrea.dellisola@med.lu.se.
  • Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Remissgatan 4, Lund 222 42, Sweden; Division of Insurance Medicine, Department of Clinical Neur…
  • Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Remissgatan 4, Lund 222 42, Sweden. Electronic address: martin.englund@med.lu.se.

Förderung

  • Greta och Johan Kocks stiftelser
  • Karolinska Institutet
  • Reumatikerförbundet
  • Vetenskapsrådet

Zitieren

APA

Magnusson, K., Turkiewicz, A., Dell'Isola, A., Kiadaliri, A., & Englund, M. (2026). Metformin and incident osteoarthritis: Causal insights from a co-twin control study. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.12.014

Vancouver

Magnusson K, Turkiewicz A, Dell'Isola A, Kiadaliri A, Englund M. Metformin and incident osteoarthritis: Causal insights from a co-twin control study. Osteoarthritis and Cartilage. 2026. doi:10.1016/j.joca.2025.12.014

BibTeX
@article{Magnusson2026,
  author = {Magnusson, Karin and Turkiewicz, Aleksandra and Dell'Isola, Andrea and Kiadaliri, Ali and Englund, Martin},
  title = {Metformin and incident osteoarthritis: Causal insights from a co-twin control study},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  doi = {10.1016/j.joca.2025.12.014}
}
Kostenlos starten →